Developer docs
API playgroundTry for free, no card

Search company profiles

Echolight

Full company profile

uuid000lxo2

Namestring
Echolight
Legal namestring
Echolight S.p.A.
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Echolight S.p.A. is an Italian medical device company founded in 2010 as a spin-off of the Italian National Research Council (CNR), headquartered in Lecce with US operations through wholly-owned Echolight Medical Corp. (Houston, TX and Kenmore, WA). The company develops and commercializes REMS (Radiofrequency Echographic Multi Spectrometry), a proprietary, patented ultrasound-based bone densitometry technology that measures bone mineral density and microarchitectural quality at the lumbar vertebrae and femoral neck without ionizing radiation. Its core product line — EchoS and its variants (EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) — is complemented by the EchoStudio software suite (Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, Gynecology) and dedicated ultrasound probes.

The technology is clinically validated across 10,000+ subjects in multicenter international studies and supported by a proprietary 15,000+ subject reference database. Regulatory assets include FDA 510(k) clearance (2017), CE mark, ISO 13485:2016 and ISO 9001:2015 certifications, Italian ISS guideline inclusion (2020), Poland 2026 guideline inclusion, and a US CPT code assignment (2024). Differentiating features include automatic artifact rejection (addressing DXA overestimation in osteoarthritic patients), radiation-free operation enabling use in pregnant women, children, and frequent monitoring, and portable device form factors suitable for pharmacy, home care, and bedside use.

Echolight monetizes primarily through one-time hardware sales of bone densitometry devices and separately licensed EchoStudio software modules, distributed globally through 40+ resellers and a direct enterprise sales force in North America. Customers include hospitals, specialized osteoporosis and bone health clinics, retail and clinical pharmacies (point-of-care screening), wellness and anti-aging centers, home care providers, and research institutions (including NASA for bedrest and spaceflight bone-loss studies). The company is led by founder and CEO Sergio Casciaro, with Mike Yuja serving as Chief Commercial Officer and North America General Manager since January 2025.

Short descriptiontext

Echolight is an Italian medical device company that develops and sells REMS, a patented radiation-free ultrasound technology for bone densitometry at the lumbar vertebrae and femoral neck. It serves hospitals, pharmacies, home care providers, and wellness centers globally through 40+ distributors and direct US sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLecce, Italy
HQ citystring
Lecce
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bone densitometry devices, radiation-free ultrasound, osteoporosis diagnostics, bone health assessment, medical imaging equipment
Industry1 code
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Bone Densitometry Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Bone Densitometry Hardware Sales
TypeHardware Sales
Description

Sale of EchoS, EchoStation, EchoHybrid, and EchoHybrid Plus device configurations including main ultrasound unit, probes, and accessories. Devices are sold directly and through distributor network globally.

echolightmedical.com
2Software Licenses
TypeOne Time License
Description

EchoStudio software applications sold separately including Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, and Gynecology modules.

echolightmedical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1EchoS
Description

The only ultrasound bone densitometer for assessment of bone condition at lumbar vertebrae and femoral neck using proprietary R.E.M.S. technology. Available in portable and fixed configurations.

echolightmedical.com
+5 more records
Core offering1 text field

Echolight manufactures and sells the EchoS family of ultrasound bone densitometers that use proprietary REMS (Radiofrequency Echographic Multi Spectrometry) technology to assess bone mineral density and microarchitectural quality at the lumbar vertebrae and proximal femur without ionizing radiation. The offering includes multiple hardware configurations (portable and workstation variants) for hospitals, clinics, pharmacies, home care, and wellness settings, paired with a suite of EchoStudio software modules covering bone density, body composition, fragility score, fracture risk, skeletal, and gynecological assessments. Customers include medical facilities, retail pharmacies, wellness centers, and research organizations such as NASA.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • REMS and DXA show no statistical difference in FRAX fracture risk probabilities using femoral neck T-score, enabling equivalent clinical decision-making
+2 more records
Product overview1 text field

Echolight offers a comprehensive bone health assessment ecosystem centered on REMS (Radiofrequency Echographic Multi Spectrometry) technology. The core product is EchoS - a radiation-free bone densitometer available in multiple configurations (EchoS, EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) for different clinical settings. Software modules (EchoStudio Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, Gynecology) extend functionality. Hardware accessories include specialized ultrasound probes. The system replaces traditional DXA with portable ultrasound technology that provides BMD measurements, T/Z-scores, and proprietary Fragility Scores for fracture risk prediction without ionizing radiation.

Product and service14 records
1EchoS
CategoryBone Densitometry Hardware
Description

Main bone densitometer using proprietary REMS technology. A radiation-free ultrasound device for assessing bone density and quality at lumbar vertebrae and femoral neck, providing BMD, T-Score, Z-Score, and Fragility Score; available in standard and portable versions.

2EchoS Plus
CategoryBone Densitometry Hardware
Description

Enhanced configuration of the EchoS bone densitometer with additional features targeted at hospitals, clinics, pharmacies, and home care settings.

3EchoStation
CategoryBone Densitometry Hardware
Description

Dedicated workstation configuration of the EchoS bone densitometer designed for hospitals and clinics requiring a fixed setup for bone density assessment.

4EchoHybrid
CategoryBone Densitometry Hardware
Description

Bone densitometry configuration pairing the EchoS main ultrasound unit with a cart and medical PC for clinical centers and remote locations requiring maximum versatility.

5EchoHybrid Plus
CategoryBone Densitometry Hardware
Description

Top-of-range bone densitometry configuration combining the main ultrasound unit, cart and medical PC, and a hard carrying case with integrated PC for maximum deployment versatility.

6EchoStudio Bone Density
CategoryBone Densitometry Software
Description

Software module for assessment of bone mineral density on lumbar vertebrae (L1-L4) and femoral neck, providing BMD (g/cm2), T-Score, and Z-Score for osteoporosis diagnosis.

7EchoStudio Body Composition
CategoryBone Densitometry Software
Description

Software module for analysis of body component distribution, providing BMI, percentage Fat Mass, and Basal Metabolic Rate measurement during ultrasound scan.

8EchoStudio Fragility Score
CategoryBone Densitometry Software
Description

Software module that evaluates internal bone structure quality and bone fragility through proprietary spectral analysis independent of BMD.

9EchoStudio Fracture Risk
CategoryBone Densitometry Software
Description

Software module providing 5-year fracture risk assessment on lumbar vertebrae and femoral neck by combining fragility information with BMD.

10EchoStudio Skeletal
CategoryUltrasound Imaging Software
Description

Software application for musculoskeletal ultrasound evaluations used with the linear probe for skeletal assessments.

11EchoStudio Gynecology
CategoryUltrasound Imaging Software
Description

Software application for gynecological ultrasound evaluations used with the endocavity probe.

12Convex Probe
CategoryUltrasound Hardware Accessory
Description

Convex ultrasound probe for abdominal ultrasound evaluations and wide-field imaging applications with the EchoS platform.

13Linear Probe
CategoryUltrasound Hardware Accessory
Description

40mm linear probe matched with EchoStudio Skeletal software for musculoskeletal ultrasound evaluations.

14Endocavity Probe
CategoryUltrasound Hardware Accessory
Description

Endocavity ultrasound probe matched with EchoStudio Gynecology software for gynecological ultrasound evaluations.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1NASA
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-10-21
Description

NASA uses Echolight's proprietary REMS technology to monitor bone changes in human bedrest studies and assess effects of unloading on bone mass during spaceflight simulations. The portable device (size of small suitcase) enables fast scan times under 10 minutes with edge analytics and ability to scan frequently without radiation. Prof. Aenor Sawyer (UCSF Space Health) highlighted the strategic importance for longer missions to Moon and Mars where real-time bone loss monitoring becomes critical.

prnewswire.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

Co-marketing partnership between Echolight Medical and Aurora Spine Corporation. Both companies operate in the spine and bone health space, with Aurora Spine focused on spinal surgery solutions and Echolight providing bone density assessment. The partnership enables cross-promotion to shared healthcare provider audiences.

3Italian National Research Council (CNR)
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Echolight originated as a spin-off from CNR. The company maintains ongoing collaboration with CNR researchers for clinical studies and R&D activities. First multi-center clinical validation study for REMS technology was conducted in collaboration with CNR at major osteoporosis reference centers worldwide.

echolightmedical.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

GE Healthcare's Lunar iDXA and Prodigy bone densitometers are the other dominant DXA franchise globally. Echolight's REMS targets the same clinical use case (lumbar spine + femoral neck BMD) with an ultrasound-based, non-ionizing approach.

TypeDirect peer
Description

Hologic's Horizon and Discovery DXA systems are the leading bone densitometry devices in hospitals and women's health centers. Echolight competes head-to-head with Hologic's installed base by offering a radiation-free alternative for osteoporosis diagnosis.

TypeEmerging player
Description

CompuMed provides bone densitometry analysis software and telereading services, including OsteoGram and iNSTech platforms. Comparable as a software/analytics player serving osteoporosis screening workflows.

TypeDirect peer
Description

OsteoSys (South Korea) manufactures quantitative ultrasound (QUS) bone densitometers such as the Sonost series, targeting the same osteoporosis screening segment as Echolight EchoS. Direct ultrasound-bone-densitometry competitor in the portable and primary-care channel.

TypeDirect peer
Description

Mindways provides quantitative CT (QCT) and DXA software for volumetric and trabecular bone density assessment. Competes in the bone densitometry analytics and software layer adjacent to Echolight's EchoStudio software modules.

TypeEmerging player
Description

BeamMed markets Sunlight Omnisense quantitative ultrasound bone densitometers at peripheral skeletal sites. Direct technology competitor in ultrasound-based bone assessment, though focused on peripheral rather than axial sites.

TypeEmerging player
Description

Medimaps' TBS iNsight software adds Trabecular Bone Score analysis on top of DXA scans, addressing bone microarchitecture quality — the same clinical need that Echolight's Fragility Score targets. Comparable as a software-plus-imaging player in bone quality assessment.

8Norland (Swissray/Swissmed)
TypeDirect peer
Description

Norland has historically supplied DXA bone densitometry systems for clinical and research use. Competes in the same hospital/research bone densitometry market that Echolight addresses via REMS technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Echolight

Bone Densitometry Equipmentecholightmedical.com

Echolight is an Italian medical device company that develops and sells REMS, a patented radiation-free ultrasound technology for bone densitometry at the lumbar vertebrae and femoral neck. It serves hospitals, pharmacies, home care providers, and wellness centers globally through 40+ distributors and direct US sales.

What Echolight does

Echolight S.p.A. is an Italian medical device company founded in 2010 as a spin-off of the Italian National Research Council (CNR), headquartered in Lecce with US operations through wholly-owned Echolight Medical Corp. (Houston, TX and Kenmore, WA). The company develops and commercializes REMS (Radiofrequency Echographic Multi Spectrometry), a proprietary, patented ultrasound-based bone densitometry technology that measures bone mineral density and microarchitectural quality at the lumbar vertebrae and femoral neck without ionizing radiation. Its core product line — EchoS and its variants (EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) — is complemented by the EchoStudio software suite (Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, Gynecology) and dedicated ultrasound probes.

The technology is clinically validated across 10,000+ subjects in multicenter international studies and supported by a proprietary 15,000+ subject reference database. Regulatory assets include FDA 510(k) clearance (2017), CE mark, ISO 13485:2016 and ISO 9001:2015 certifications, Italian ISS guideline inclusion (2020), Poland 2026 guideline inclusion, and a US CPT code assignment (2024). Differentiating features include automatic artifact rejection (addressing DXA overestimation in osteoarthritic patients), radiation-free operation enabling use in pregnant women, children, and frequent monitoring, and portable device form factors suitable for pharmacy, home care, and bedside use.

Echolight monetizes primarily through one-time hardware sales of bone densitometry devices and separately licensed EchoStudio software modules, distributed globally through 40+ resellers and a direct enterprise sales force in North America. Customers include hospitals, specialized osteoporosis and bone health clinics, retail and clinical pharmacies (point-of-care screening), wellness and anti-aging centers, home care providers, and research institutions (including NASA for bedrest and spaceflight bone-loss studies). The company is led by founder and CEO Sergio Casciaro, with Mike Yuja serving as Chief Commercial Officer and North America General Manager since January 2025.

Echolight firmographics

Firmographics
Name
Echolight
Legal name
Echolight S.p.A.
Website
https://echolightmedical.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Echolight is an Italian medical device company that develops and sells REMS, a patented radiation-free ultrasound technology for bone densitometry at the lumbar vertebrae and femoral neck. It serves hospitals, pharmacies, home care providers, and wellness centers globally through 40+ distributors and direct US sales.
Ownership category
akta.pro rank

Echolight industry classification

Industry
Product category
Bone Densitometry Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Bone densitometry devices
  • Radiation-free ultrasound
  • Osteoporosis diagnostics
  • Bone health assessment
  • Medical imaging equipment

Where Echolight is headquartered

Location

Headquarters

HQ city
Lecce
HQ country
Italy
HQ region
Europe

Offices3 records

Markets served

Echolight business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Bone Densitometry Hardware Sales: Sale of EchoS, EchoStation, EchoHybrid, and EchoHybrid Plus device configurations including main ultrasound unit, probes, and accessories. Devices are sold directly and through distributor network globally.
  2. Software Licenses: EchoStudio software applications sold separately including Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, and Gynecology modules.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Echolight product offering

Product offering

Core offering

Echolight manufactures and sells the EchoS family of ultrasound bone densitometers that use proprietary REMS (Radiofrequency Echographic Multi Spectrometry) technology to assess bone mineral density and microarchitectural quality at the lumbar vertebrae and proximal femur without ionizing radiation. The offering includes multiple hardware configurations (portable and workstation variants) for hospitals, clinics, pharmacies, home care, and wellness settings, paired with a suite of EchoStudio software modules covering bone density, body composition, fragility score, fracture risk, skeletal, and gynecological assessments. Customers include medical facilities, retail pharmacies, wellness centers, and research organizations such as NASA.

Product overview

Echolight offers a comprehensive bone health assessment ecosystem centered on REMS (Radiofrequency Echographic Multi Spectrometry) technology. The core product is EchoS - a radiation-free bone densitometer available in multiple configurations (EchoS, EchoS Plus, EchoStation, EchoHybrid, EchoHybrid Plus) for different clinical settings. Software modules (EchoStudio Bone Density, Body Composition, Fragility Score, Fracture Risk, Skeletal, Gynecology) extend functionality. Hardware accessories include specialized ultrasound probes. The system replaces traditional DXA with portable ultrasound technology that provides BMD measurements, T/Z-scores, and proprietary Fragility Scores for fracture risk prediction without ionizing radiation.

Differentiator

Problem solved

Functional benefit

Brands

  • EchoS: The only ultrasound bone densitometer for assessment of bone condition at lumbar vertebrae and femoral neck using proprietary R.E.M.S. technology. Available in portable and fixed configurations.
  • EchoStation
  • EchoS Plus
  • EchoHybrid
  • EchoHybrid Plus
  • EchoStudio

Products and services

  • EchoS Main bone densitometer using proprietary REMS technology. A radiation-free ultrasound device for assessing bone density and quality at lumbar vertebrae and femoral neck, providing BMD, T-Score, Z-Score, and Fragility Score; available in standard and portable versions.
  • EchoS Plus Enhanced configuration of the EchoS bone densitometer with additional features targeted at hospitals, clinics, pharmacies, and home care settings.
  • EchoStation Dedicated workstation configuration of the EchoS bone densitometer designed for hospitals and clinics requiring a fixed setup for bone density assessment.
  • EchoHybrid Bone densitometry configuration pairing the EchoS main ultrasound unit with a cart and medical PC for clinical centers and remote locations requiring maximum versatility.
  • EchoHybrid Plus Top-of-range bone densitometry configuration combining the main ultrasound unit, cart and medical PC, and a hard carrying case with integrated PC for maximum deployment versatility.
  • EchoStudio Bone Density Software module for assessment of bone mineral density on lumbar vertebrae (L1-L4) and femoral neck, providing BMD (g/cm2), T-Score, and Z-Score for osteoporosis diagnosis.
  • EchoStudio Body Composition Software module for analysis of body component distribution, providing BMI, percentage Fat Mass, and Basal Metabolic Rate measurement during ultrasound scan.
  • EchoStudio Fragility Score Software module that evaluates internal bone structure quality and bone fragility through proprietary spectral analysis independent of BMD.
  • EchoStudio Fracture Risk Software module providing 5-year fracture risk assessment on lumbar vertebrae and femoral neck by combining fragility information with BMD.
  • EchoStudio Skeletal Software application for musculoskeletal ultrasound evaluations used with the linear probe for skeletal assessments.
  • EchoStudio Gynecology Software application for gynecological ultrasound evaluations used with the endocavity probe.
  • Convex Probe Convex ultrasound probe for abdominal ultrasound evaluations and wide-field imaging applications with the EchoS platform.
  • Linear Probe 40mm linear probe matched with EchoStudio Skeletal software for musculoskeletal ultrasound evaluations.
  • Endocavity Probe Endocavity ultrasound probe matched with EchoStudio Gynecology software for gynecological ultrasound evaluations.

Quantifiable outcome

  • REMS and DXA show no statistical difference in FRAX fracture risk probabilities using femoral neck T-score, enabling equivalent clinical decision-making
  • +2 more outcomes

Companies that use Echolight

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles5 records

Echolight technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Echolight partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • NASAflagshipStrategic or Co-development Partner · 21 October 2024NASA uses Echolight's proprietary REMS technology to monitor bone changes in human bedrest studies and assess effects of unloading on bone mass during spaceflight simulations. The portable device (size of small suitcase) enables fast scan times under 10 minutes with edge analytics and ability to scan frequently without radiation. Prof. Aenor Sawyer (UCSF Space Health) highlighted the strategic importance for longer missions to Moon and Mars where real-time bone loss monitoring becomes critical.
  • Aurora Spine CorporationcoreGTM or Marketing PartnerCo-marketing partnership between Echolight Medical and Aurora Spine Corporation. Both companies operate in the spine and bone health space, with Aurora Spine focused on spinal surgery solutions and Echolight providing bone density assessment. The partnership enables cross-promotion to shared healthcare provider audiences.
  • Italian National Research Council (CNR)flagshipStrategic or Co-development PartnerEcholight originated as a spin-off from CNR. The company maintains ongoing collaboration with CNR researchers for clinical studies and R&D activities. First multi-center clinical validation study for REMS technology was conducted in collaboration with CNR at major osteoporosis reference centers worldwide.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Echolight competitors and assessment

Company assessment

Direct peers

  • GE Healthcare: GE Healthcare's Lunar iDXA and Prodigy bone densitometers are the other dominant DXA franchise globally. Echolight's REMS targets the same clinical use case (lumbar spine + femoral neck BMD) with an ultrasound-based, non-ionizing approach.
  • Hologic: Hologic's Horizon and Discovery DXA systems are the leading bone densitometry devices in hospitals and women's health centers. Echolight competes head-to-head with Hologic's installed base by offering a radiation-free alternative for osteoporosis diagnosis.
  • OsteoSys: OsteoSys (South Korea) manufactures quantitative ultrasound (QUS) bone densitometers such as the Sonost series, targeting the same osteoporosis screening segment as Echolight EchoS. Direct ultrasound-bone-densitometry competitor in the portable and primary-care channel.
  • Mindways: Mindways provides quantitative CT (QCT) and DXA software for volumetric and trabecular bone density assessment. Competes in the bone densitometry analytics and software layer adjacent to Echolight's EchoStudio software modules.
  • Norland (Swissray/Swissmed): Norland has historically supplied DXA bone densitometry systems for clinical and research use. Competes in the same hospital/research bone densitometry market that Echolight addresses via REMS technology.

Emerging players

  • CompuMed: CompuMed provides bone densitometry analysis software and telereading services, including OsteoGram and iNSTech platforms. Comparable as a software/analytics player serving osteoporosis screening workflows.
  • BeamMed (Sunlight Medical): BeamMed markets Sunlight Omnisense quantitative ultrasound bone densitometers at peripheral skeletal sites. Direct technology competitor in ultrasound-based bone assessment, though focused on peripheral rather than axial sites.
  • Medimaps Group: Medimaps' TBS iNsight software adds Trabecular Bone Score analysis on top of DXA scans, addressing bone microarchitecture quality — the same clinical need that Echolight's Fragility Score targets. Comparable as a software-plus-imaging player in bone quality assessment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Echolight social profiles

Digital presence

Echolight compliance and trust

Trust signal

Compliance4 records

Echolight financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Echolight leadership team

Management profile

Number of profiles

Profiles2 records

Echolight subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Echolight funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Echolight M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Echolight

What does Echolight do?

Echolight manufactures and sells the EchoS family of ultrasound bone densitometers that use proprietary REMS (Radiofrequency Echographic Multi Spectrometry) technology to assess bone mineral density and microarchitectural quality at the lumbar vertebrae and proximal femur without ionizing radiation. The offering includes multiple hardware configurations (portable and workstation variants) for hospitals, clinics, pharmacies, home care, and wellness settings, paired with a suite of EchoStudio software modules covering bone density, body composition, fragility score, fracture risk, skeletal, and gynecological assessments. Customers include medical facilities, retail pharmacies, wellness centers, and research organizations such as NASA.

Is Echolight a public or private company?

Echolight is a private company. It is classified as venture growth investor backed and is currently operating.

When was Echolight founded?

Echolight was founded in 2010. It employs 11 to 50 people.

Where is Echolight based?

Echolight is headquartered in Lecce, Italy, in the Europe region.

How does Echolight make money?

Two revenue lines are on record. Bone Densitometry Hardware Sales are the primary driver. The others are software Licenses.

Who are Echolight's main competitors?

Direct peers on record are GE Healthcare, Hologic, OsteoSys, Mindways and Norland (Swissray/Swissmed). Emerging players are CompuMed, BeamMed (Sunlight Medical) and Medimaps Group.

Does Echolight have an API?

No public API is recorded for Echolight.

What industry is Echolight in?

Echolight's product category is Bone Densitometry Equipment. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmiWeb.comBone Densitometer Market Growth, Opportunities, and Industry Forecast 2026The global bone densitometer market is projected to grow at a rate of 4.5% by 2026, driven by rising osteoporosis prevalence, an aging population, and technological advancements in bone densitometry, though high device costs may restrain growth. North America currently holds the largest market share, with Europe and Asia-Pacific following; the latter is expected to see strong future growth due to increasing osteoporosis awareness and healthcare spending. Major market players are pursuing strategic initiatives including partnerships, acquisitions, and product launches, such as Echolight Medical's co-marketing partnership with Aurora Spine Corporation and DMS Imaging's extended manufacturing contract with FUJIFILM Healthcare Group covering ASEAN and MEA regions.PharmiWeb.comBone Densitometer Market 2026 | Growth Overview, Facts & Figures, Segmentation, Future Trends, and Historical AnalysisThe global bone densitometer market is projected to grow at a rate of 4.5% by 2026, driven by increasing prevalence of osteoporosis, rising geriatric populations, and advancements in bone densitometry technology. North America currently holds the largest market share, while the Asia-Pacific region is expected to experience robust growth due to rising osteoporosis awareness and healthcare spending. Notable strategic developments include co-marketing agreements and product launches by companies such as Echolight Medical, Aurora Spine Corporation, and DMS Imaging, though high device costs may constrain market expansion.PR NewswireECHOLIGHT TO DEMONSTRATE RADIATION-FREE BONE DENSITY SCANNING AT RSNA 2025Echolight will exhibit its radiation-free bone densitometry technology at RSNA 2025, focusing on its REMS ultrasound system that measures bone density without ionizing radiation. Studies published validate REMS's accuracy and potential for use in pregnant women, enabling safer monitoring of bone health over time. The company, based in Italy with U.S. offices, markets its portable devices globally, emphasizing its innovation in personalized bone health diagnosis.PR NewswireECHOLIGHT APPOINTS MIKE YUJA AS NEW CHIEF COMMERCIAL OFFICER AND NORTH AMERICA GENERAL MANAGEREcholight, a global innovator in bone densitometry, has appointed Mike Yuja as Chief Commercial Officer and North America General Manager, reporting directly to CEO and founder Sergio Casciaro. Yuja succeeds Tom McLaughlin, who is retiring, and will be responsible for developing sales strategy, overseeing full P&L management, and driving business growth in the US market. Yuja brings over 20 years of experience in diagnostic imaging, capital equipment, and pharmaceuticals, having held senior roles at Mallinckrodt, Covidien, Guerbet, and most recently Jubilant Radiopharma.BioSpaceAurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight MedicalAurora Spine and Echolight Medical announced a joint co-marketing agreement to promote each other's products for bone health assessment and spinal implants. The partnership combines Echolight's radiation-free EchoS densitometer with Aurora's DEXA Technology-based patient-matched implants. The companies expect to expand healthcare access through this collaboration.GlobeNewswireAurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight MedicalAurora Spine and Echolight Medical announced a co-marketing agreement to promote each other's products for bone health assessment and spinal implants. The partnership combines Echolight's radiation-free EchoS densitometer with Aurora's DEXA-based patient-matched implants. The companies expect to expand healthcare access through this collaboration.PR NewswireEcholight Medical awarded Vizient contract to provide improved technology in bone density diagnosticsEcholight Medical has been awarded a multi-year contract by Vizient Inc. to make its Radiofrequency Echographic Multi Spectrometry (REMS) technology available at contracted pricing to Vizient's members, which represent over half of US healthcare organizations. This agreement aims to expand access to the radiation-free bone density diagnostic tool, allowing for earlier diagnosis and prevention of osteoporosis-related fractures. The deal provides Echolight with entry into a network managing more than $100 billion in annual purchasing volume.PR NewswireNew Diagnostic Technology Showcased During Osteoporosis Awareness MonthEcholight Medical is introducing its radiation-free REMS diagnostic technology at the Florida Orthopedic Society Annual Scientific Meeting in Tampa, Florida, as part of Osteoporosis Awareness Month. The technology, which measures bone density and fracture risk without radiation, is the first portable bone densitometer capable of point-of-care bone health assessment. According to the company, 54 million Americans are affected by osteoporosis and low bone density, with more than half of Americans age 50 and older at high risk for bone fracture.